You are here
News & Events
Vertex Appoints Lloyd Carney to its Board of Directors
“We are thrilled to have Lloyd join the Vertex Board. His wealth of leadership and management experience paired with his passion for technology and innovation bring an invaluable perspective to the Vertex leadership team,” said Jeffrey Leiden, M.D., Ph.D., Chairman, President and Chief Executive Officer of Vertex.
“It’s an honor to join an organization with a strong track record of
discovering new medicines to treat life-threatening diseases like cystic
Prior to his role atChaSerg, Mr. Carney served as Chief
Executive Officer of Brocade Communications Systems, a global supplier
of networking hardware and software, until its acquisition by
Mr. Carney holds a Bachelor of Science degree in electrical engineering
Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious and life-threatening diseases. In addition to clinical development programs in CF, Vertex has more than a dozen ongoing research programs focused on the underlying mechanisms of other serious diseases.
Founded in 1989 in
For additional information and the latest updates from the company, please visit www.vrtx.com.
Vertex Pharmaceuticals Incorporated
Michael Partridge, 617-341-6108
Eric Rojas, 617-961-7205
Zach Barber, 617-341-6470
North America: +1 617-341-6992